OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Drug-Drug Interactions of Direct Oral Anticoagulants (DOACs): From Pharmacological to Clinical Practice
Nicola Ferri, E. Colombo, Marco Tenconi, et al.
Pharmaceutics (2022) Vol. 14, Iss. 6, pp. 1120-1120
Open Access | Times Cited: 75

Showing 1-25 of 75 citing articles:

Anticoagulants: A Short History, Their Mechanism of Action, Pharmacology, and Indications
Marco Heestermans, Géraldine Poenou, Hind Hamzeh‐Cognasse, et al.
Cells (2022) Vol. 11, Iss. 20, pp. 3214-3214
Open Access | Times Cited: 72

Low-Density Lipoprotein Cholesterol-Lowering Drugs: A Narrative Review
Nicola Ferri, Massimiliano Ruscica, Sergio Fazio, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 4, pp. 943-943
Open Access | Times Cited: 14

Perioperative Management of Patients Taking Direct Oral Anticoagulants
James D. Douketis, Alex C. Spyropoulos
JAMA (2024) Vol. 332, Iss. 10, pp. 825-825
Closed Access | Times Cited: 14

Incidence of intracranial bleeding in mild traumatic brain injury patients taking oral anticoagulants: a systematic review and meta-analysis
Armin Karamian, Ali Seifi, Amin Karamian, et al.
Journal of Neurology (2024) Vol. 271, Iss. 7, pp. 3849-3868
Closed Access | Times Cited: 8

Potential interactions between antimicrobials and direct oral anticoagulants: population-based cohort and case-crossover study
Angel Wong, Charlotte Warren‐Gash, Krishnan Bhaskaran, et al.
Heart Rhythm (2025)
Open Access | Times Cited: 1

Drug–Drug Interactions of FXI Inhibitors: Clinical Relevance
Nicola Ferri, E. Colombo, Alberto Corsini
Hematology Reports (2024) Vol. 16, Iss. 1, pp. 151-163
Open Access | Times Cited: 5

Evaluation of siRNA dependent knockdowns of drug metabolizing enzymes in multi-well array culture of primary human hepatocyte spheroids for estimation of fraction metabolized
Lena Brücker, Dominik Jacob, Lena C. Preiss, et al.
Drug Metabolism and Disposition (2025) Vol. 53, Iss. 4, pp. 100062-100062
Closed Access

Anticoagulant treatment of cancer-associated thromboembolism
Isabelle Mahé, Didier Mayeur, Françis Couturaud, et al.
Archives of cardiovascular diseases (2023) Vol. 117, Iss. 1, pp. 29-44
Open Access | Times Cited: 11

Anticoagulation in Patients with Chronic Kidney Disease
Elias John Elenjickal, Christoforos K. Travlos, Pedro Marques, et al.
American Journal of Nephrology (2023) Vol. 55, Iss. 2, pp. 146-164
Open Access | Times Cited: 11

UGT2B15 single nucleotide polymorphism reduces dabigatran acylglucuronide formation in humans
Jin‐Woo Park, Jong‐Min Kim, Young Yoon Bang, et al.
Frontiers in Pharmacology (2025) Vol. 15
Open Access

Understanding Drug Interactions in Antiplatelet Therapy for Atherosclerotic Vascular Disease: A Systematic Review
Xiangqian Huang, Jiahao Song, Xiaoming Zhang, et al.
CNS Neuroscience & Therapeutics (2025) Vol. 31, Iss. 2
Open Access

Impact of cytochrome P-450 3A4 enzyme/P-glycoprotein inducing antiseizure medications on direct oral anticoagulant therapy
Sean M. McNary, Madalyn Kuhlenberg, Lucia F. Basilio, et al.
Blood Coagulation & Fibrinolysis (2025)
Closed Access

Abelacimab versus Rivaroxaban in Patients with Atrial Fibrillation
Christian T. Ruff, Erica L. Goodrich, Marc S. Sabatine
New England Journal of Medicine (2025) Vol. 392, Iss. 15, pp. 1556-1557
Closed Access

Cancer‐associated thrombosis and drug–drug interactions of antithrombotic and antineoplastic agents
Hatice Bölek, Yüksel Ürün
Cancer (2023) Vol. 129, Iss. 20, pp. 3216-3229
Open Access | Times Cited: 10

Novel Thiourea and Oxime Ether Isosteviol-Based Anticoagulants: MD Simulation and ADMET Prediction
Marcin Gackowski, Mateusz Jędrzejewski, Sri Satya Medicharla, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 2, pp. 163-163
Open Access | Times Cited: 3

Direct oral anticoagulants and venous malformations: literature review and retrospective study of 29 patients
Eugénie Lagneaux, Laurence M. Boon, Nicole Revençu, et al.
Research and Practice in Thrombosis and Haemostasis (2024) Vol. 8, Iss. 3, pp. 102400-102400
Open Access | Times Cited: 3

Risk Factors for Rivaroxaban-Related Bleeding Events—Possible Role of Pharmacogenetics: Case Series
Livija Šimičević, Ana Marija Slišković, Majda Vrkić Kirhmajer, et al.
Pharmacy (2023) Vol. 11, Iss. 1, pp. 29-29
Open Access | Times Cited: 8

Efficacy of Warfarin Therapy Guided by Pharmacogenetics: A Real-world Investigation Among Han Taiwanese
Ting‐Yuan Liu, Hsing‐Yu Hsu, Ying‐Shu You, et al.
Clinical Therapeutics (2023) Vol. 45, Iss. 7, pp. 662-670
Closed Access | Times Cited: 8

In silico design, docking simulation, and ANN-QSAR model for predicting the anticoagulant activity of thiourea isosteviol compounds as FXa inhibitors
Marcin Gackowski, Burhanuddin Madriwala, Marcin Koba
Chemical Papers (2023) Vol. 77, Iss. 11, pp. 7027-7044
Open Access | Times Cited: 7

Page 1 - Next Page

Scroll to top